Simulex, Inc. | Synthetic Environments for Analysis and Simulation™

Pharmaceuticals

With our SEAS technology, we can simulate the various risk-return payoffs, future scenarios on likely introduction of a drug or expiration of a patent. Implementation for any marketing plan, merger, take-over, price cuts or R&D investment can be achieved in virtual space.

Intelligent agents can represent small, medium, and larger pharmaceutical firms. Each simulation can be customized as per client specifications.